Identity
- Trade Name
- UNBRANDED FDA UDI
- Generic Name
- Intra-arterial needle FDA UDI
- Device Name
- Arterial Needle FDA UDI
- Model / Reference
- 5005NS FDA UDI
- Description
- Arterial Needle FDA UDI
Identifiers
- Primary DI / UDI-DI
- 00848340009365 FDA UDI
- FDA Product Code
- DRC FDA UDI
- GMDN Term
- Intra-arterial needle FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 870.1390 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Ethylene Oxide FDA UDI
Category: Intra-arterial needle
Unbranded by Advance Medical Designs, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Intra-arterial needle.
- Guidewire Introducer Needle — REMINGTON MEDICAL, INC. · Class I
- ClosureFast — Covidien LP · Class I
- ClosureFast — Covidien LP · Class I
- ClosureFast — Covidien LP · Class I
- Guidewire Introducer Needle Winged Base Plate — REMINGTON MEDICAL, INC. · Class I
- Guidewire Introducer Needle — REMINGTON MEDICAL, INC. · Class I
- ClosureFast — Covidien LP · Class I
- Guidewire Introducer Needle Guidewire Access Needle — REMINGTON MEDICAL, INC. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Advance Medical Designs, Inc.
Sources (1)
- FDA UDI f1f15411-09c3-4879-bffd-4e697c8fb8c9 33 fields · synced Jun 8, 2026